RANOLAZINE IN ISCHEMIC HEART DISEASE

RANOLAZINE IN ISCHEMIC HEART DISEASE

Show other versions (1)

<p>Study results of a new anti-anginal drug (an inhibitor of sodium channels — ranolazine) are presented. Indications, contraindications, major clinical trials of the drug in patients with ischemic heart disease are considered.</p>

Bibliographic Details
Main Author:	V. P. Lupanov
Format:	Article
Language:	English
Published:	Столичная издательская компания 2015-12-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	ишемическая болезнь сердца стенокардия острый коронарный синдром медикаментозное лечение ранолазин
Online Access:	http://www.rpcardio.ru/jour/article/view/423

Similar Items

EVALUATION OF RANOLAZINE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CHRONIC STABLE ANGINA. RESULTS FROM THE TERISA RANDOMIZED CLINICAL TRIAL (TYPE 2 DIABETES EVALUATION OF RANOLAZINE IN SUBJECTS WITH CHRONIC STABLE ANGINA)
Published: (2015-09-01)

THE INFLUENCE OF PSYCHOSOCIAL FACTORS ON THE DEVELOPMENT OF ISCHEMIC HEART DISEASE AND ACUTE CORONARY SYNDROME
by: K. G. Kozhokar, et al.
Published: (2016-06-01)

Modern principles of chronic coronary heart disease management. The role of antianginal medications
by: S. Yu. Martsevich
Published: (2005-06-01)

Nitrates in complex angina management during the age of aggressive coronary atherosclerosis treatment
by: D. M. Aronov, et al.
Published: (2005-10-01)

Perioperative Hemostatic Features in Patients with Acute Coronary Syndrome and Chronic Coronary Heart Disease
by: Yu. V. Nikiforov, et al.
Published: (2007-08-01)

Modern strategy, management and outcomes for stable ischemic heart disease patients
by: V. P. Lupanov
Published: (2016-02-01)

Secondary prevention drug therapy of coronary heart disease and myocardial infarction
by: V. P. Lupanov
Published: (2013-12-01)

Statins in clinical practice
by: A. S. Sivkov, et al.
Published: (2010-04-01)

Clinical effects of statins: focusing on simvastatin
by: D. M. Aronov, et al.
Published: (2009-04-01)

ОСТРЫЙ КОРОНАРНЫЙ СИНДРОМ: КОМПЛЕКСНЫЙ ВЗГЛЯД НА ПРОБЛЕМУ, ЗНАЧЕНИЕ ГОСПИТАЛЬНОГО И АМБУЛАТОРНОГО ЭТАПОВ ЛЕЧЕНИЯ ПАЦИЕНТОВ
by: И. С. Скопец, et al.
Published: (2012-06-01)

THE PROBLEM OF INTERCHANGEABILITY OF DRUG PRODUCTS. TRIMETAZIDINE IS AN EFFECTIVE TREATMENT OF PATIENTS WITH ISCHEMIC HEART DISEASE
by: L. E. Chekuldaeva, et al.
Published: (2015-12-01)

MYOCARDIAL REVASCULARIZATION IN ACUTE CORONARY SYNDROME IN UDMURT REPUBLIC
by: Natalya Mikhailovna Kuzmina
Published: (2017-10-01)

Prognostic value of the cardiac fraction of fatty acid binding protein in patients with non-ST elevation acute coronary syndrome with concomitant type 2 diabetes
by: S. A. Berns, et al.
Published: (2019-06-01)

THE HISTORY OF CARDIOREHABILITATION: FROM A STRICT 2-MONTH BED REST TO SCANDINAVIAN WALKING
by: K. A. Volodina, et al.
Published: (2017-08-01)

IMMUNO-INFLAMATORY RESPONSE IN ISCHEMIC HEART DISEASE
by: N. E. Zakirova, et al.
Published: (2015-12-01)

Place of the novel drug ranolazine in the treatment of coronary artery disease
by: GA Baryshnikova, et al.
Published: (2014-12-01)

HIGH SELECTIVE LONG-ACTING Β1-BLOCKER WITH A VASODILATING EFFECT NEBIVOLOL IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE
by: V. P. Lupanov
Published: (2015-12-01)

Male and female mortality rates due to acute types of coronary artery disease in five-year age groups in the Russian Federation: what do the numbers mean?
by: I. V. Samorodskaya, et al.
Published: (2023-01-01)

DEATH CAUSES AND THEIR PREDICTION IN PATIENTS WITH THE ST SEGMENT ELEVATION ACUTE CORONARY SYNDROME AND PRE-HOSPITAL THROMBOLYSIS
by: S. N. Morozov, et al.
Published: (2013-04-01)

Enhanced external counterpulsation in acute coronary syndrome, as a part of the pre-coronary artery bypass surgery treatment
by: V. A. Markov, et al.
Published: (2011-10-01)

Stable coronary heart disease treatment: focus on beta-adrenoblockers
by: V. I. Makolkin
Published: (2008-12-01)

PROGNOSIS OF ONE-DAY MORTALITY AND PROTEIN GROWTH AND DAMAGE FACTORS IN ACUTE CORONARY SYNDROME
by: G. Kh. Kayumova, et al.
Published: (2017-12-01)

New potential of Trimetazidine MB for coronary heart disease treatment in the real-world clinical practice: results of the Russian multi-centre randomised study PERSPECTIVE (Part II)
by: M. G. Bubnova, et al.
Published: (2011-12-01)

A CLINICAL CASE OF VASOSPASTIC ANGINA IN A PATIENT WITH GASTROESOPHAGEAL REFLUX DISEASE
by: Irina Vladimirovna Ponomarenko, et al.
Published: (2023-09-01)

ASSESSMENT OF RELATIONSHIP FOR GRACE SCORE AND CORONARY LESION SEVERITY IN YOUNG PATIENTS WITH ACUTE CORONARY SYNDROME
by: I. S. Skopets, et al.
Published: (2016-06-01)

The role of increased lipoprotein (a) and apolipoprotein B-100 levels, and their link to cholesterol and triglyceride concentration in coronary heart disease patients
by: G. G. Arabidze, et al.
Published: (2006-10-01)

THE DYNAMICS OF LIFE QUALITY PARAMETERS WITH NICORANDIL USAGE IN STABLE CORONARY HEART DISEASE PATIENTS (RESULTS OF THE OBSERVATION STUDY “NIKEA”)
by: S. Yu. Martsevich, et al.
Published: (2017-12-01)

Molsidomine in the treatment of patients with stable coronary artery disease
by: VP Lupanov
Published: (2014-12-01)

Importance of early diagnostics of chronic obstructive pulmonary disease in patients with coronary heart disease
by: A. N. Kuznetsov, et al.
Published: (2011-06-01)

Prospective rAndomized, single-blind, mulTicenter control clinical study of sirolimus-eluting coRonary stent “Calypso” vs everolimus-elutIng cOronary stenT “Xience Prime”: design and rationale for “PATRIOT” trial
by: А. А. Прохорихин, et al.
Published: (2016-12-01)

ANALYSIS OF PRE-HOSPITAL TREATMENT OF ACUTE CORONARY SYNDROME
by: O. V. Reshetko, et al.
Published: (2015-12-01)

Relationship between coronary artery calcification and osteopenic syndrome in men with coronary heart disease
by: T. A. Raskina, et al.
Published: (2016-06-01)

Aggressive statin therapy in acute coronary syndrome: therapeutic potential of atorvastatin in the daily dose of 80 mg
by: A. N. Britov
Published: (2009-12-01)

MYOCARDIAL REMODELING IN ISCHEMIC HEART DISEASE
by: A. N. Zakirova, et al.
Published: (2016-01-01)

Comparative characteristics of coated stents used in endovascular treatment of patients with coronary heart disease
by: А. Г. Осиев, et al.
Published: (2015-10-01)

Antagonisty kal'tsiya v lechenii arterial'noy gipertonii (issledovanie ETNA)
by: I E Chazova, et al.
Published: (2005-03-01)

SUMMARY OF CONCLUSIONS FROM A CONSENSUS PANEL OF EXPERTS ON THE IMPORTANCE OF RIVAROXABAN IN THE MANAGEMENT OF PATIENTS RECOVERING FROM ACUTE CORONARY SYNDROME
by: M. Ya. Ruda, et al.
Published: (2015-12-01)

Pharmacodynamics and clinical effectiveness of clopidogrel and atorvastin in patients with acute coronary syndrome and hyperlipidaemia
by: A. S. Sivkov, et al.
Published: (2009-08-01)

Various protocols of extracorporeal shock wave therapy in the treatment of stable angina
by: M. M. Shcherbak, et al.
Published: (2019-11-01)

Prospective rAndomized, single-blind, mulTicenter study of sirolimus-eluting coRonary stent “Calypso” vs everolimus-eluting cOronary stenT “XiencePrime”: results of the PATRIOT trial
by: A. A. Prokhorikhin, et al.
Published: (2017-11-01)